Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Metopimazine mesylate by Neurogastrx for Emesis (Vomiting): Likelihood of Approval
Metopimazine mesylate is under clinical development by Neurogastrx and currently in Phase II for Emesis (Vomiting). According to GlobalData, Phase...
Data Insights
Metopimazine mesylate by Neurogastrx for Nausea: Likelihood of Approval
Metopimazine mesylate is under clinical development by Neurogastrx and currently in Phase II for Nausea. According to GlobalData, Phase II...